Breast Biopsy Devices Market Size to Touch USD 1.70 Bn By 2035

Regional Insights

North America accounted for the largest revenue share in the worldwide market in 2025, and it is anticipated that the region would continue to dominate the market during the forecast period. The U.S. and Canada, two of the region’s biggest economies, are the main sources of income for the market value in the area. The prospective market for medical tourism in the area underpins the value of the prevailing regional market.

U.S. Market Trends

The U.S. market is driven by breast cancer awareness, an improved reimbursement system, superior diagnostic centers, and a high number of patients using vacuum-assisted biopsies. The increasing demand for image-guided biopsy procedures in hospitals and outpatient settings in the U.S. More research and initiatives for early detection also spurred market growth.

Why is Europe Growing in the Breast Biopsy Devices Market?

Europe is expected to grow at a considerable CAGR in the upcoming period, owing to the presence of robust screening programs for cancer detection, increased uptake of early diagnosis technologies, and increasing investment in healthcare. Awareness regarding breast biopsy technologies also played an important role in fueling market growth in Europe. In addition, advancements in imaging technology and favorable healthcare policies have also driven growth in the market.

Will Latin America Grow in the Breast Biopsy Devices Market?

Latin America is considered to be a significantly growing area, due to its projected stable growth owing to improved healthcare infrastructure, increased awareness about breast cancer, and growing availability of diagnostic imaging techniques. Private healthcare systems are also playing an instrumental role in driving market growth in the region. Increased focus by governments towards the health of women and improved access to urban healthcare facilities are some other important factors contributing to regional demand.

Breast Biopsy Devices Market Companies

• Cook Medical Incorporated
• Becton,
• Dickinson and Company
• Devicor Medical Products Inc.
• C.R. Bard, Inc., Hologic Inc
• Argon Medical Devices
• Planmed OY
• Encapsule Medical Devices LLC
• Ethicon Endo-Surgery (Johnson and Johnson)

Recent Developments

• In March 2019, Dune Medical Devices revealed the results of the first human test of their smart biopsy device. The smart Biopdy from Dune Medical is a continuous soft tissue biopsy device that provides electrical samples in real time using small key needle detectors. To enhance diagnosis and readout, these electrical pulses are compared to astronomical data. The in-man stage signals the start of a more involved, exhaustive clinical investigation aimed at identifying the precise tissue makeup of the breast.

Segment Covered in the Report

By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

By Guidance

• Image-Guided Biopsy
• Mammography-guided Stereotactic Biopsy
• Ultrasound-guided Biopsy
• MRI-guided Biopsy
• Other Guidance Techniques
• Liquid Biopsy
• NGS-based Biopsy
• PCR-based Biopsy
• Microarray-based Biopsy

By Type

• Needle Breast Biopsy
• Core Needle Biopsy (CNB)
• Fine Needle Aspiration Biopsy (FNAB)
• Vacuum-assisted Biopsy (VAB)
• Open Surgical Breast Biopsy
• Excisional
• Incisional
• Liquid Breast Biopsy
• Circulating Tumor Cells
• Circulating Tumor DNA (CtDNA)
• Other Biomarkers

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Check this Report this: Hematopoietic Stem Cell Transplantation Market

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/2402

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344